Sapiens leads Euro launch of DBS/Parkinson's collaboration; ConforMIS hires Genzyme vet as CFO

 @FierceMedDev: EarlySense in Israel raised $15M for hospital beds with sensors built in. Via Globes. More | Follow @FierceMedDev

 @MarkHFierce: HeartWare boosted revenue in Q3 2012, thanks to expanded Int'l approval for its HVAD device. But net losses soared. More | Follow @MarkHFierce

 @DamianFierce: Covance took a 7% profit hit in Q3 but still topped Wall Street estimates. More | Follow @DamianFierce

> SetPoint Medical generated positive clinical results for a first-in-human study using a neuromodulation device to treat rheumatoid arthritis. Item

> ConforMIS, an orthopedic implant device maker, has hired veteran Genzyme executive Peter Traynor as its new chief financial officer. Item

> California-based Presbia has submitted an investigational device exemption with the FDA for an implantable microlens designed to treat presbyopia, the age-related loss of near vision. Item

> Sapiens ($SPNS) is leading a new collaborative European project focused on developing a new patient-specific approach for deep brain stimulation therapy for Parkinson's disease patients. Release

> Roche ($RHHBY) has launched an additional diagnostic test designed to help better manage patients with epithelial ovarian cancer. Release

> AdvaMed is debuting a new web portal that links veterans seeking nobs to med tech-related mentors and recruiters. Item

Biotech News

 @FierceBiotech: From FierceCRO.com: Icon launches new functional service model. More | Follow @FierceBiotech

 @JohnCFierce: How about that--AstraZeneca gets pos. data in late-stage constipation study. Partnered with Nektar ('09 1.5B deal). More | Follow @JohnCFierce

 @RyanMFierce: Boehringer Ingelheim takes hepC message online. News | Follow @RyanMFierce

> CV fears cloud AstraZeneca's positive results for $1.5B constipation program. Article

> Abbott, Gilead impress with upbeat results for oral hep C drugs. Report

> Shares of Clovis, Clavis blasted by failure of pancreatic cancer drug. Story

> Tau theory comes center stage in Alzheimer's R&D as amyloid advocates regroup. News

Pharma News

@FiercePharma: In $491mn Rapamune settlement, Pfizer to plead guilty to a misdemeanor. News | Follow @FiercePharma

> Pfizer racks up $600M-plus in Wyeth-related legal settlements. Report

> Sistema aims to buy Russia's Veropharm in potential $636M deal. Article

> Pfizer under fire in U.K. for paying little-to-no corporate tax. Story

Biotech IT News

> GNS turns to Big Data to crack multiple myeloma. News

> FDA updates IT after GAO lashing. Item

> Boehringer Ingelheim takes hep C message online. Article

> Private equity interest in Merge prompts breakup speculation. Story

> Maverix enters genomics software game with Silicon Valley sizzle. Report

CRO News

> Parexel looks to the future with university partnership. Item

> Covance posts profit drop but beats predictions in Q3. Story

> DiscoveRx snags BioSeek for drug development. News

> CRA buys Radiant Research to increase trial capacity. Article

> AMRI narrows losses on strong Q3. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.